Early Lung Cancer Diagnosis in HIV Infected Population With an Important Smoking History With Low Dose CT: a Pilot Study

NCT01207986 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 450

Last updated 2026-04-23

No results posted yet for this study

Summary

Early Lung Cancer diagnosis in a HIV-infected population with an important smoking history with low-dose CT: a pilot study: the HIV-CHEST study Objectives The main objective of this study is to evaluate the prevalence of lung cancers detected by low-dose computed tomography (CT) in a HIV-infected population with an important smoking history. Other objectives are (1) the evaluation of the types of lung cancers in this population, as well as (2) the staging of non small cell lung cancers, (3) the description of risk factors for all lung cancers, if they are numerous enough, and (4) the number of complications of diagnosis procedures during the study.

Conditions

Interventions

RADIATION

Low dose computed tomography (CT)

Sponsors & Collaborators

  • ANRS, Emerging Infectious Diseases

    lead OTHER_GOV

Principal Investigators

  • Alain Makinson · University Hospital, Montpellier

  • Antoine Cheret · CHU Tourcoing

  • Sophie Abgrall · Hospital Avicenne

  • Pierre Delamonicca · CHU NICE

  • Pierre Tattevin · Pontchaillou

  • Isabelle Poizot Martin · St Marguerite Marseille

  • Francois Raffi · Hotel Dieu Nantes

  • Claudine Duvivier · Necker Paris

  • David Zucman · Foch Suresnes

  • Jean Louis Couderc · Foch Suresnes

  • Tristan Ferry · La Croix Rousse Lyon

  • Jean Marc Mauboussin · Nîmes, CH Caremeau

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2012-06-30
Completion
2014-08-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01207986 on ClinicalTrials.gov